Extended High-frequency Hearing and Speech Perception
Sponsor
Brian Monson (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05435989
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD) (NIH)
480
1
1
54.7
8.8
Study Details
Study Description
Brief Summary
This study examines the effects of low-pass filtering speech on speech perception.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
480 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Extended High-frequency Hearing and Speech Perception
Actual Study Start Date
:
Nov 9, 2021
Anticipated Primary Completion Date
:
Jun 1, 2026
Anticipated Study Completion Date
:
Jun 1, 2026
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Normal-hearing listeners
|
Diagnostic Test: Reduced extended high-frequency audibility
This study examines the effects of low-pass filtering speech on speech perception.
|
Outcome Measures
Primary Outcome Measures
- Speech recognition or localization score [Day 1]
Speech recognition or localization scores are assessed using alternative forced choice procedures implemented with custom software scripts (e.g. in Matlab)
Eligibility Criteria
Criteria
Ages Eligible for Study:
19 Years
to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
-
native speakers of American English
-
normal hearing 250-8000 Hz
Exclusion Criteria:
-
non-native speakers of American English
-
hearing loss
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | University of Illinois Urbana-Champaign | Champaign | Illinois | United States | 61820 |
Sponsors and Collaborators
- Brian Monson
- National Institute on Deafness and Other Communication Disorders (NIDCD)
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Brian Monson,
Assistant Professor,
University of Illinois at Urbana-Champaign
ClinicalTrials.gov Identifier:
NCT05435989
Other Study ID Numbers:
- AH181
- R01DC019745
First Posted:
Jun 28, 2022
Last Update Posted:
Aug 1, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No